Kyverna Therapeutics, Inc. KYTX Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s interest paid?
- Kyverna Therapeutics, Inc. (KYTX) reported interest paid of $568K in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s interest paid changed year-over-year?
- Kyverna Therapeutics, Inc.'s interest paid increased by 2889.5% year-over-year, from $19K to $568K.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s interest paid?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s interest paid has grown at a 49.0% compound annual growth rate (CAGR), from $187K to $415K.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.